Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

about

Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Item

http://www.wikidata.org/entity/Q47391460

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@en

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@nl

type

Item

label

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@en

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@nl

prefLabel

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@en

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@nl

P1476

Is Exercise Training Appropria ...... Inotropic Infusion? A Review.

@en

P2093

Masanobu Taya

http://www.w3.org/2001/XMLSchema#string

P2860

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy

Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation

Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure

Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training.

Cardiac rehabilitation in very old patients: data from the Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008)--official report of the Italian Association for Cardiovascular Prevention, Rehabilitation, and Epidemiology.

Chronic inotropic therapy in end-stage heart failure.

Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Wasting as independent risk factor for mortality in chronic heart failure.

Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.

P304

1179546817751438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1179546817751438

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eisuke Amiya

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29326534

http://www.w3.org/2001/XMLSchema#string

P932

5757424

http://www.w3.org/2001/XMLSchema#string